academic article

• Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial..  JAMA.  318:57-67. 2017
• Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth. 2016
• Safety and Pharmacokinetics of Multiple Dose myo-Inositol in Preterm..  Pediatric research.  :-. 2016
• Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial..  JAMA : the journal of the American Medical Association.  312:2629-2639. 2014
• Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). 2014
• Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk..  Pediatric research.  74:721-729. 2013
• Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes.  J Pediatr.  161:222-228. 2012
• Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.  E Engl J Med.  367:2495-2504. 2012
• Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants..  American journal of respiratory and critical care medicine.  183:1715-1722. 2011
• Target ranges of oxygen saturation in extremely preterm infants..  The New England journal of medicine.  362:1959-1969. 2010
• Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron..  Pediatrics.  114:1287-1291. 2004